AOD 9604 – Synthetic Peptide Fragment

PRODUCT SPECIFICATIONS

• Chemical Name: L-tyrosyl-L-leucyl-L-arginyl-L-isoleucyl-L-valyl-L-glutaminyl-L-cysteinyl-L-arginyl-L-seryl-L-valyl-L-alpha-glutamyl-glycyl-L-seryl-L-cysteinyl-glycyl-L-phenylalanine cyclic (7→14)-disulfide
• Peptide Classification: Synthetic growth-hormone-derived peptide fragment
• Peptide Type: Short-chain laboratory research peptide
• Listed Molecular Formula: C78H123N23O23S2
• Molecular Weight: ~1814 Da (reported in the existing literature description)
• Purity: ≥99% (HPLC verified)
• Listed Solvent Systems: Solution and phosphate-buffered saline (PBS)
• Storage: −20°C, protected from light and moisture
• Molecular Structure: Modified growth-hormone-derived peptide fragment with a cyclic disulfide bridge

For laboratory research use only. Not for use in humans or animals.

MAIN DESCRIPTION

AOD 9604 is a synthetic peptide fragment described as Tyr-hGH Frag 177-191. Its defined molecular structure provides laboratory research context for metabolic signaling, peptide-enzyme interactions, and intracellular biochemical pathway measurements.

Biochemical investigations can examine structure-activity relationships and pathway responses in controlled in-vitro systems. Interpretation depends on material identity, concentrations, solvent compatibility, experimental controls, and the specific assay model.

EXPERIMENTAL & ANALYTICAL USE

• Peptide-enzyme interaction mapping in in-vitro assays
• Intracellular metabolic signaling measurements
• Structure-activity relationships across synthetic peptide scaffolds
• Biochemical modeling of enzyme-associated pathways
• Analytical characterization within multi-component assay systems

Toxicology and Detection Methods

Laboratory analytical research uses liquid chromatography-tandem mass spectrometry (LC-MS/MS) to characterize AOD-9604 and related fragments in biological matrices.

Metabolite Sequence: The existing analytical description identifies CRSVEGSCG as a stable urinary metabolite associated with proteolytic cleavage of terminal residues.

Analytical Sensitivity: The listed solid-phase extraction (SPE) method description reports a limit of detection of 50 pg/mL. Detection depends on the extraction method, matrix, instrument settings, and validation conditions. Consult the original method for the experimental parameters studied.

Handling and Stability

The supplied format is described as a lyophilized white powder in acetate-salt form. The existing handling information lists slight solubility in DMSO and aqueous systems, alongside Solution and PBS as laboratory solvent contexts. Evaluate compatibility, pH, and solubility within the selected assay rather than assuming uniform behavior across buffers.

The existing acetate-form handling description includes mild acetic acid as a solvent-system consideration. Select the solvent system according to material documentation and analytical requirements. Store at −20°C and limit repeated freezing and thawing when managing laboratory aliquots.

Chemical Structure Reference

The retained molecular images provide structure references for AOD-9604 and its cyclic disulfide bridge between Cys7 and Cys14. The listed hexadecapeptide formula is C78H123N23O23S2.

MOLECULAR & TECHNICAL CHARACTERISTICS

The listed analytical purity is ≥99%, HPLC verified. Identity, mass, composition, and disulfide-bridge characterization inform material assessment. HPLC purity alone does not establish the absence of all truncated species, solution stability, or experimental reproducibility.

Laboratory stability measurements require defined solvent, temperature, light exposure, and analytical conditions. Review the batch documentation and assess material integrity under the conditions of the intended assay.

SCIENTIFIC RESEARCH CONTEXT

• Peptide-associated metabolic signaling
• Intracellular enzyme-pathway measurements
• Synthetic peptide structure-function relationships
• In-vitro biochemical pathway modeling

RESEARCH USE CLASSIFICATION

For laboratory research use only. Not for use in humans or animals.

The material is supplied for biochemical assays, analytical characterization, and laboratory education. Interpret component and pathway literature according to the molecular form and experimental conditions described in the original publications.

FEATURES / HIGHLIGHTS

• Synthetic growth-hormone-derived peptide fragment
• Metabolic signaling and intracellular enzyme assay context
• Cyclic disulfide structure for analytical characterization
• Listed purity of ≥99%, HPLC verified
• Laboratory solubility and stability assessment
• Research Use Only laboratory reagent

Why Profound Aminos

Profound Aminos supplies AOD 9604 for metabolic signaling, adipocyte pathway, and cellular toxicology assays. Listed characterization includes cyclic disulfide-bridge integrity, purity validation, mass measurements, and LC-MS identity information. Temperature-controlled packaging is part of laboratory materials handling.

Additional research contexts include lipid-mobilization pathways, beta-3 adrenergic receptor measurements, energy-homeostasis signaling, and cellular metabolic flexibility. Evaluate each endpoint within the defined experimental system.

References

The existing bibliography identifies the PubChem compound summary for AOD 9604; Cox, H.D., et al., for detection and in-vitro metabolism research; and Heffernan, M., et al., for growth-hormone fragment and lipid-metabolism research. Consult the original publications for compound identities, assay models, and analytical conditions.

STORAGE INSTRUCTIONS

• Store at −20°C in a sealed container
• Protect from light and moisture
• Limit repeated freezing and thawing of laboratory solutions
• Maintain documented laboratory materials-handling conditions

FAQs

What is AOD 9604 used for in laboratory research?

AOD 9604 provides research context for peptide-associated metabolic signaling, intracellular enzyme interactions, structure-activity relationships, and analytical characterization in controlled in-vitro systems.

What structural features describe AOD 9604?

AOD 9604 is described as a synthetic growth-hormone-derived peptide fragment, Tyr-hGH Frag 177-191, with a cyclic disulfide bridge between Cys7 and Cys14. The listed formula is C78H123N23O23S2 and approximate molecular weight is 1814 Da.

What is the listed analytical purity?

The listed purity is ≥99%, HPLC verified. Review the material identity and batch analytical data when assessing suitability for a specific assay. Purity alone does not guarantee consistent experimental outcomes.

What is the intended use of the supplied material?

For laboratory research use only. Not for use in humans or animals.

What storage conditions are listed for AOD 9604?

Store at −20°C in a sealed container, protected from light and moisture. Limit repeated freezing and thawing of laboratory solutions and assess stability in the selected solvent system.

For laboratory research use only. Not for use in humans or animals.